These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 31469018)

  • 1. An update on genetic risk assessment and prevention: the role of genetic testing panels in breast cancer.
    Piccinin C; Panchal S; Watkins N; Kim RH
    Expert Rev Anticancer Ther; 2019 Sep; 19(9):787-801. PubMed ID: 31469018
    [No Abstract]   [Full Text] [Related]  

  • 2. The Clinical Utility of Next Generation Sequencing Results in a Community-Based Hereditary Cancer Risk Program.
    Bunnell AE; Garby CA; Pearson EJ; Walker SA; Panos LE; Blum JL
    J Genet Couns; 2017 Feb; 26(1):105-112. PubMed ID: 27276934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome.
    Yurgelun MB; Allen B; Kaldate RR; Bowles KR; Judkins T; Kaushik P; Roa BB; Wenstrup RJ; Hartman AR; Syngal S
    Gastroenterology; 2015 Sep; 149(3):604-13.e20. PubMed ID: 25980754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic risk assessment and prevention: the role of genetic testing panels in breast cancer.
    Lerner-Ellis J; Khalouei S; Sopik V; Narod SA
    Expert Rev Anticancer Ther; 2015; 15(11):1315-26. PubMed ID: 26523341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanded Gene Panel Use for Women With Breast Cancer: Identification and Intervention Beyond Breast Cancer Risk.
    O'Leary E; Iacoboni D; Holle J; Michalski ST; Esplin ED; Yang S; Ouyang K
    Ann Surg Oncol; 2017 Oct; 24(10):3060-3066. PubMed ID: 28766213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new paradigm of genetic testing for hereditary breast/ovarian cancers.
    Kwong A; Chen JW; Shin VY
    Hong Kong Med J; 2016 Apr; 22(2):171-7. PubMed ID: 26980575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel.
    Tung N; Battelli C; Allen B; Kaldate R; Bhatnagar S; Bowles K; Timms K; Garber JE; Herold C; Ellisen L; Krejdovsky J; DeLeonardis K; Sedgwick K; Soltis K; Roa B; Wenstrup RJ; Hartman AR
    Cancer; 2015 Jan; 121(1):25-33. PubMed ID: 25186627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rescreening for genetic mutations using multi-gene panel testing in patients who previously underwent non-informative genetic screening.
    Frey MK; Kim SH; Bassett RY; Martineau J; Dalton E; Chern JY; Blank SV
    Gynecol Oncol; 2015 Nov; 139(2):211-5. PubMed ID: 26296696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.
    Desmond A; Kurian AW; Gabree M; Mills MA; Anderson MJ; Kobayashi Y; Horick N; Yang S; Shannon KM; Tung N; Ford JM; Lincoln SE; Ellisen LW
    JAMA Oncol; 2015 Oct; 1(7):943-51. PubMed ID: 26270727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Systematic Comparison of Traditional and Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Genes in More Than 1000 Patients.
    Lincoln SE; Kobayashi Y; Anderson MJ; Yang S; Desmond AJ; Mills MA; Nilsen GB; Jacobs KB; Monzon FA; Kurian AW; Ford JM; Ellisen LW
    J Mol Diagn; 2015 Sep; 17(5):533-44. PubMed ID: 26207792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Changing Landscape of Genetic Testing for Inherited Breast Cancer Predisposition.
    Afghahi A; Kurian AW
    Curr Treat Options Oncol; 2017 May; 18(5):27. PubMed ID: 28439798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care.
    Graffeo R; Livraghi L; Pagani O; Goldhirsch A; Partridge AH; Garber JE
    Breast Cancer Res Treat; 2016 Dec; 160(3):393-410. PubMed ID: 27734215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Li-Fraumeni syndrome: not a straightforward diagnosis anymore-the interpretation of pathogenic variants of low allele frequency and the differences between germline PVs, mosaicism, and clonal hematopoiesis.
    Batalini F; Peacock EG; Stobie L; Robertson A; Garber J; Weitzel JN; Tung NM
    Breast Cancer Res; 2019 Sep; 21(1):107. PubMed ID: 31533767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer.
    Lin PH; Kuo WH; Huang AC; Lu YS; Lin CH; Kuo SH; Wang MY; Liu CY; Cheng FT; Yeh MH; Li HY; Yang YH; Hsu YH; Fan SC; Li LY; Yu SL; Chang KJ; Chen PL; Ni YH; Huang CS
    Oncotarget; 2016 Feb; 7(7):8310-20. PubMed ID: 26824983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer.
    Kurian AW; Ward KC; Hamilton AS; Deapen DM; Abrahamse P; Bondarenko I; Li Y; Hawley ST; Morrow M; Jagsi R; Katz SJ
    JAMA Oncol; 2018 Aug; 4(8):1066-1072. PubMed ID: 29801090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Next-generation sequencing for hereditary breast and gynecologic cancer risk assessment.
    Kurian AW; Kingham KE; Ford JM
    Curr Opin Obstet Gynecol; 2015 Feb; 27(1):23-33. PubMed ID: 25502425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multi-gene panel study in hereditary breast and ovarian cancer in Colombia.
    Cock-Rada AM; Ossa CA; Garcia HI; Gomez LR
    Fam Cancer; 2018 Jan; 17(1):23-30. PubMed ID: 28528518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Panel Gene Testing for Hereditary Breast and Ovarian Cancer on Patients.
    Lumish HS; Steinfeld H; Koval C; Russo D; Levinson E; Wynn J; Duong J; Chung WK
    J Genet Couns; 2017 Oct; 26(5):1116-1129. PubMed ID: 28357778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-gene Panel Testing in Breast Cancer Management.
    Fountzilas C; Kaklamani VG
    Cancer Treat Res; 2018; 173():121-140. PubMed ID: 29349761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Updates on breast cancer genetics: Clinical implications of detecting syndromes of inherited increased susceptibility to breast cancer.
    Cobain EF; Milliron KJ; Merajver SD
    Semin Oncol; 2016 Oct; 43(5):528-535. PubMed ID: 27899183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.